Related Experiment Video
Updated: May 31, 2026
![Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol
Published on: September 21, 2021
TREK-1 isoforms generated by alternative translation initiation display different susceptibility to the
Michaela Eckert1, Brigitte Egenberger, Frank Döring
1Institute of Physiology, University of Würzburg, Würzburg, Germany.
Abstract:
Two-pore-domain K(+) (K(2)P) channels are highly expressed in neurons and cardiac myocytes. In this study we investigated the potency of the antidepressant fluoxetine to inhibit brain and cardiac K(2)P channels, TREK-1, TASK-1 and THIK-1. Maximal sensitivity was detected for TREK-1, which was inhibited by 77% when expressed in HEK-293 cells and Xenopus oocytes. Alternative translation initiation (ATI) generates two different protein products from a single transcript of TREK-1. Electrophysiological analysis of two polypeptides engineered by mutagenesis (TREK-1[M53I], TREK-1[ΔN52]) revealed reduced current amplitude and K(+) selectivity of the truncated TREK-1 isoform. The sensitivity of TREK-1[ΔN52] to fluoxetine decreased by 70%, indicating that the first 52 amino acids are essential for TREK-1 sensitivity to this drug.
Insights
Fluoxetine, an antidepressant, potently inhibits TREK-1, a brain and cardiac potassium channel. Specific protein variants of TREK-1 show altered drug sensitivity, highlighting the importance of its N-terminal region.
Area of Science:
- Neuroscience
- Cardiology
- Molecular Biology
Background:
- Two-pore-domain potassium (K(2)P) channels are crucial in neuronal and cardiac function.
- Understanding drug interactions with these channels is vital for therapeutic development.
Purpose of the Study:
- To investigate the inhibitory effects of fluoxetine on brain and cardiac K(2)P channels, specifically TREK-1, TASK-1, and THIK-1.
- To elucidate the role of alternative translation initiation in TREK-1 function and drug sensitivity.
Main Methods:
- HEK-293 cell and Xenopus oocyte expression systems.
- Electrophysiological analysis of wild-type and mutated TREK-1 channels.
- Site-directed mutagenesis to generate TREK-1 variants (TREK-1[M53I], TREK-1[ΔN52]).
Main Results:
- Fluoxetine maximally inhibited TREK-1 channels by 77%.
- Alternative translation initiation of TREK-1 produces isoforms with altered current amplitude and K(+) selectivity.
- The TREK-1[ΔN52] isoform exhibited a 70% decrease in fluoxetine sensitivity, indicating the N-terminus is critical for drug interaction.
Conclusions:
- Fluoxetine is a potent inhibitor of TREK-1 channels.
- The N-terminal region of TREK-1, specifically the first 52 amino acids, is essential for its sensitivity to fluoxetine.
- Alternative translation initiation significantly impacts TREK-1 channel function and drug response.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Leaky Scanning
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

